Netherlands· NL-86855a61a4e5

Trimethoprim CF 300 mg, tabletten

A trimethoprim product containing trimethoprim, registered in Netherlands by Centrafarm B.V.. The same ATC class is registered in 12 of our 19 countries.

ATC J01EA01

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about trimethoprimAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Trimethoprim is registered in 12 of 19 countries.

Countries holding a registration under ATC J01EA01 (trimethoprim), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
6 of them publish a price we can compare per daily dose

Search trimethoprim products by name

Trimethoprim · ATC J01EA01

12 / 19 countries

Canada
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of trimethoprim costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Trimethoprim · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

FR France$2.50

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: TRIMETHOPRIM
Manufacturer: Centrafarm B.V.
Country: Netherlands (NL)
ATC code: J01EA01
ATC class: Trimethoprim
Defined daily dose: 0.4 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
55723

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

138 interactions on record for trimethoprim.

Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check trimethoprim against other medicines How interaction checks work

Trimethoprim · interactions on record

138 records

12 severe
33 moderate
2 minor
91 info

Most severe, free to view

Potassium chlorideA12BA01severe
Potassium citrateA12BA02severe
Potassium gluconateA12BA05severe
Potassium chlorideB05XA01severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Trimethoprim in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All trimethoprim products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

Austria · Motrim, Triprim
Germany · Infectotrimet
Denmark · Trimopan
Estonia · Trimetop
Spain · Tediprima
Finland · Trimetin, Trimopan
France · Delprim
United Kingdom (Northern Ireland) · Trimethoprim, Trimethoprim Accord-Uk
Ireland · Monotrim, Monotrim Monotrim 10 Mg/Ml Oral Suspension
Iceland · Idotrim, Trimetoprim Viatris
Lithuania · Trimetop
Latvia · Trimetop
Norway · Trimetoprim Orion
Poland · Trimesan, Urotrim
Sweden · Idotrim, Trimetoprim Viatris

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/f09cba8d-824b-484d-beaa-a81bee2c621e
GET /v1/drugs/f09cba8d-824b-484d-beaa-a81bee2c621e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h55723_smpc.pdf",
  "strength": null,
  "atc_label": "Trimethoprim",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg55723",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMZETMEELGLYCOLAAT",
    "POVIDON (E 1201)",
    "TALK (E 553b)"
  ],
  "substances": [
    "TRIMETHOPRIM"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h55723.pdf",
  "authorised_at": "1983/01/04",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "55723",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about trimethoprim.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console